The FDA has given accelerated approval to a groundbreaking T cell-based therapy from Adaptimmune for synovial sarcoma, becoming the first new treatment for the rare soft tissue cancer in more than ...

The company achieved its first FDA approval in August 2024 for Tecelra (afami-cel), a T cell receptor (TCR) therapy for adults with metastatic synovial sarcoma. This approval marked several firsts ...

Eldiara Doucette, a TikTok star who details her journey with rare cancer synovial sarcoma online, shared a lighthearted ...

Nagpur: In a remarkable achievement, AIIMS Nagpur successfully treated a 26-year-old MBBS student suffering from synovial cell sarcoma, a rare and aggressive cancer affecting the chest wall. The young ...

Under the agreement, AGC Biologics will manufacture the lentiviral vector used to produce lete-cel, an engineered T-cell therapy targeting the NY-ESO-1 antigen. This support will include activities ...